Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

  1. Öcal, O.
  2. Schütte, K.
  3. Zech, C.J.
  4. Loewe, C.
  5. van Delden, O.
  6. Vandecaveye, V.
  7. Verslype, C.
  8. Gebauer, B.
  9. Sengel, C.
  10. Bargellini, I.
  11. Iezzi, R.
  12. Philipp, A.
  13. Berg, T.
  14. Klümpen, H.J.
  15. Benckert, J.
  16. Pech, M.
  17. Gasbarrini, A.
  18. Amthauer, H.
  19. Bartenstein, P.
  20. Sangro, B.
  21. Malfertheiner, P.
  22. Ricke, J.
  23. Seidensticker, M.
Revue:
European Journal of Nuclear Medicine and Molecular Imaging

ISSN: 1619-7089,  1619-7070

Année de publication: 2022

Volumen: 49

Número: 13

Pages: 4716-4726

Type: Article

DOI: 10.1007/S00259-022-05920-8 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus